Robert T. Lum

935 citations

19 papers · 759 indexed · h-index 16

Physiology top 5%
Organic Chemistry top 5%
- Synthetic Organic Chemistry Methods 2
Inorganic Chemistry top 10%
Oncology
- Cancer-related Molecular Pathways 2
Molecular Biology
- Ubiquitin and proteasome pathways 3
- Peroxisome Proliferator-Activated Receptors 2
Virology
- HIV Research and Treatment 2
Computational Theory and Mathematics
- Computational Drug Discovery Methods 2
Pharmacology
- Inflammatory mediators and NSAID effects 2
Infectious Diseases
- HIV/AIDS drug development and treatment 2

Co-authors: Stephen L. Buchwald John C. Dewan Steven R. Schow Michael M. Wick Alison Joly William A. Nugent Brett T. Watson S.S. Kerwar
Cited by: Physiology Organic Chemistry Inorganic Chemistry
Partner nations: United States South Korea

In The Last Decade

Robert T. Lum

19 papers receiving 715 citations

Peers

Countries citing papers authored by Robert T. Lum

Since Specialization

Citations

This map shows the geographic impact of Robert T. Lum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert T. Lum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert T. Lum more than expected).

Fields of papers citing papers by Robert T. Lum

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert T. Lum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert T. Lum. The network helps show where Robert T. Lum may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Robert T. Lum, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Robert T. Lum Line = papers co-authored together Robert T. Lum links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work
1	5-Substituted isophthalamides as insulin receptor sensitizers Louise Robinson,Sonia Bajjalieh,Nicholas Cairns,Robert T. Lum,Robert W. Macsata,Vara Prasad Manchem,Sophia J. Park,Sandhya Rao,Steven R. Schow,Songyuan Shi,Wayne Spevak	2008	3
2	Design, Synthesis, and Structure−Activity Relationships of Novel Insulin Receptor Tyrosine Kinase Activators Robert T. Lum,Mingshan Cheng,Cristina P. Cristobal,Ira D. Goldfine,Joseph L. Evans,James Keck,Robert W. Macsata,Vara Prasad Manchem,Yukiharu Matsumoto,Sophia J. Park,Sandhya Rao,Louise Robinson,Songyuan Shi,Wayne Spevak,Steven R. Schow	2008	14
3	Target-Related Affinity Profiling: Teliks Lead Discovery Technology Paul Beroza,Komath Damodaran,Robert T. Lum	2005	20
4	In vitro and in vivo prevention of HIV protease inhibitor‐induced insulin resistance by a novel small molecule insulin receptor activator Mingshan Cheng,Seiyu Chen,Steven R. Schow,Vara Prasad Manchem,Wayne Spevak,Cristina P. Cristobal,Songyuan Shi,Robert W. Macsata,Robert T. Lum,Ira D. Goldfine,James Keck	2004	11
5	Novel Cyclooxygenase-1 Inhibitors Discovered Using Affinity Fingerprints Nancy Hsu,Danying Cai,Komath Damodaran,Reinaldo F. Gómez,James Keck,Edgardo Laborde,Robert T. Lum,Thomas J. Macke,Graeme B. Martin,Steven R. Schow,Reyna J. Simon,Hugo O. Villar,Michael M. Wick,Paul Beroza	2004	17
6	Phase I study of TLK286 (glutathione S-transferase P1-1 activated glutathione analogue) in advanced refractory solid malignancies. Lee S. Rosen,Joseph Brown,Bernadette Laxa,Leny Boulos,Laura Reiswig,W. David Henner,Robert T. Lum,S. R. Schow,Christopher A. Maack,James Keck,Julie C Mascavage,Jacqueline A Dombroski,Reinaldo F. Gómez,Gail L. Brown	2003	24
7	A Novel Small Molecule That Directly Sensitizes the Insulin Receptor In Vitro and In Vivo Vara Prasad Manchem,Ira D. Goldfine,Ronald A. Kohanski,Cristina P. Cristobal,Robert T. Lum,Steven R. Schow,Songyuan Shi,Wayne Spevak,Edgardo Laborde,Deborah K. Toavs,Hugo O. Villar,Michael M. Wick,Michael R. Kozlowski	2001	54
8	Dibasic inhibitors of human mast cell tryptase. Part 1: Synthesis and optimization of a novel class of inhibitors Kenneth D. Rice,Anthony R. Gangloff,Elaine Y. Kuo,Jeffrey M. Dener,Vivian R. Wang,Robert T. Lum,William S. Newcomb,Chris Havel,Daun Putnam,Lynne Cregar,Martin Wong,Robert Warne	2000	25
9	A comparison of an A₁ adenosine receptor agonist (CVT‐510) with diltiazem for slowing of AV nodal conduction in guinea‐pig Stephen Snowdy,Hui Xiu Liang,Brent Blackburn,Robert T. Lum,Marek Nelson,Lisa Wang,Jürg R. Pfister,Bhavender P Sharma,Andrew A. Wolff,Luiz Belardinelli	1999	31
10	A New Structural Class of Proteasome Inhibitors that Prevent NF-κB Activation Robert T. Lum,S.S. Kerwar,Stephanie Meyer,Marek G. Nelson,Steven R. Schow,Dov Shiffman,Michael M. Wick,Alison Joly	1998	31
11	Selective inhibition of the chymotrypsin-like activity of the 20S proteasome by 5-methoxy-1-indanone dipeptide benzamides Robert T. Lum,Marek G. Nelson,Alison Joly,Amy G. Horsma,Gavin Lee,Stephanie Meyer,Michael M. Wick,Steven R. Schow	1998	33
12	CVT-313, a Specific and Potent Inhibitor of CDK2 That Prevents Neointimal Proliferation Eric E. Brooks,Nathanael S. Gray,Alison Joly,S.S. Kerwar,Robert T. Lum,Richard L. Mackman,Thea Norman,Jose Rosete,Michael W. Rowe,Steven R. Schow,Peter G. Schultz,Xingbo Wang,Michael M. Wick,Dov Shiffman	1997	111
13	Synthesis and activity of 2,6,9-trisubstituted purines Steven R. Schow,Richard L. Mackman,Cheri L. Blum,Eric E. Brooks,Amy G. Horsma,Alison Joly,S.S. Kerwar,Gavin Lee,Dov Shiffman,Marek G. Nelson,Xingbo Wang,Michael M. Wick,Xiaoming Zhang,Robert T. Lum	1997	57
14	Synthesis and Biological Evaluation of the Enantiomers of the Potent and Selective A₁-Adenosine Antagonist 1,3-Dipropyl-8-[2-(5,6-epoxynorbonyl)]- xanthine Jürg R. Pfister,Luiz Belardinelli,Gavin Lee,Robert T. Lum,Peter H. Milner,William C. Stanley,Joel Linden,Stephen P. Baker,George F. Schreiner	1997	57
15	Synthesis and antiviral activity of a novel class of HIV-1 protease inhibitors containing a heterocyclic P1′-P2′ amide bond isostere Scott K. Thompson,Alecia M. Eppley,James S. Frazee,Michael G. Darcy,Robert T. Lum,Thaddeus A. Tomaszek,Lucinda A. Ivanoff,Jane F. Morris,E. J. Sternberg,Dennis M. Lambert,Annabellee V. Fernandez,Stephen R. Petteway,Thomas D. Meek,Brian W. Metcalf,John G. Gleason	1994	38
16	Synthesis and x-ray crystal structure of a zirconocene complex of a cyclopentyne and its use to prepare bicyclic cyclopentenones Stephen L. Buchwald,Robert T. Lum,Richard A. Fisher,William M. Davis	1989	37
17	Oxygen-atom transfer from nitrous oxide. Synthesis and structure of a zirconocene oxametallacyclobutene complex G. Vaughan,Gregory L. Hillhouse,Robert T. Lum,Stephen L. Buchwald,Arnold L. Rheingold	1988	40
18	A general method for the preparation of zirconocene complexes of substituted benzynes: in situ generation, coupling reactions, and use in the synthesis of polyfunctionalized aromatic compounds Stephen L. Buchwald,Brett T. Watson,Robert T. Lum,William A. Nugent	1987	70
19	Synthesis, structure, and reactions of a zirconocene-cyclohexyne complex Stephen L. Buchwald,Robert T. Lum,John C. Dewan	1986	86

About Robert T. Lum

Robert T. Lum is a scholar working on Virology, Organic Chemistry and Physiology, having authored 19 papers that have together received 759 indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (3 papers), HIV Research and Treatment (2 papers), Computational Drug Discovery Methods (2 papers), Synthetic Organic Chemistry Methods (2 papers), Peroxisome Proliferator-Activated Receptors (2 papers), Inflammatory mediators and NSAID effects (2 papers), Cancer-related Molecular Pathways (2 papers) and HIV/AIDS drug development and treatment (2 papers). The work is most often cited by research in Physiology (54 citations), Organic Chemistry (329 citations) and Inorganic Chemistry (93 citations). Robert T. Lum has collaborated with scholars based in United States and South Korea. Frequent co-authors include Stephen L. Buchwald, John C. Dewan, Steven R. Schow, Michael M. Wick, Alison Joly, William A. Nugent, Brett T. Watson, S.S. Kerwar, Dov Shiffman and Xingbo Wang.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact